D-0420-2025 Class II Ongoing

Recalled by Empower Clinic Services, LLC Dba Empower Pharmacy — Houston, TX

FDA drug recall D-0420-2025 was initiated by Empower Clinic Services, LLC Dba Empower Pharmacy on May 2, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 8,230 vials.

Recall details

Product Type
Drugs
Report Date
May 21, 2025
Initiation Date
May 2, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,230 vials

Product description

Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by: Empower Pharmacy, 7601 N Sam Houston Pkwy W Ste 100, Houston, TX, 77064, Phone: (877) 562-8577, Compounding Date: 08/20/2024, Beyond Use by Date: 05/28/2025, Lot 202364.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

USA Nationwide

Code information

Lot #: 202364, Exp 5/28/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0420-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0420-2025. Report a data issue: hello@regdatalab.com.